Sarandria J J, Escano M, Kamangar F, Farooqui S, Montgomery E, Cunningham S C
Department of Surgery, Saint Agnes Hospital Center, Baltimore, MD, USA -
Minerva Chir. 2014 Aug;69(4):229-37.
Littoral cell tumors (LCT) are rare primary splenic neoplasms, unique for their morphologic and immunolabeling features resembling the endothelial littoral cells lining the sinusoids of the red pulp. They include the more common and typically benign littoral cell angioma, as well as the less common, potentially malignant, littoral cell hemangioendothelioma (LCHE) and the aggressive littoral cell angiosarcoma (LCAS). The most common presentation of these neoplasms is splenomegaly, and diagnosis is made histologically following biopsy or resection. To better understand these tumors, a comprehensive, international literature search was performed. Patient and tumor data, including presenting symptoms, comorbid cancers, immunosuppressive states, splenic mass and tumor size were analyzed. Massive splenomegaly (≥ 1500 g) following splenic resection, which correlates with a splenic length of 20 cm preoperatively, was found to be significantly associated with the presence of malignancy in the LCT (P<0.05).
脾窦岸细胞肿瘤(LCT)是罕见的原发性脾脏肿瘤,其形态学和免疫标记特征独特,类似于红髓血窦内衬的内皮窦岸细胞。它们包括更常见且通常为良性的脾窦岸细胞血管瘤,以及较不常见的、具有潜在恶性的脾窦岸细胞血管内皮瘤(LCHE)和侵袭性脾窦岸细胞血管肉瘤(LCAS)。这些肿瘤最常见的表现是脾肿大,通过活检或切除术后的组织学检查进行诊断。为了更好地了解这些肿瘤,我们进行了全面的国际文献检索。分析了患者和肿瘤数据,包括出现的症状、合并的癌症、免疫抑制状态、脾脏肿块和肿瘤大小。脾切除术后出现的巨大脾肿大(≥1500克)与术前脾脏长度20厘米相关,发现其与LCT中恶性肿瘤的存在显著相关(P<0.05)。